Enalapril for Congestive Heart Failure

A. Hallstrom, M. J. Gillespie, K. S. Channer, T. Rogers, C. J C Roberts, J. R. Rees, L. G. Dennick, C. S. Maskin, J. H. Meyer, W. E. Schotz, E. R. Squibb, B. W. Brown, J. Zatuchni, J. Kjekshus, K. L. Swedberg Wilhelmsen, M. Packer

Research output: Contribution to journalLetter

3 Scopus citations

Abstract

To the Editor: A layman reading the article on enalapril and congestive heart failure by the CONSENSUS trial study group (June 4 issue)* would reach the following conclusions: if he had class IV congestive heart failure, he should take enalapril for up to three months, and after that it probably wouldn't make much difference; if he was not taking vasodilators, he probably should take them concurrently; and if he was taking vasodilators, he should definitely stop taking enalapril after about three months. As clinical-trials methodologists, we would like to point out that the expense of putting together the machinery to…

Original languageEnglish (US)
Pages (from-to)1349-1351
Number of pages3
JournalNew England Journal of Medicine
Volume317
Issue number21
DOIs
StatePublished - Nov 19 1987

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Enalapril for Congestive Heart Failure'. Together they form a unique fingerprint.

  • Cite this

    Hallstrom, A., Gillespie, M. J., Channer, K. S., Rogers, T., Roberts, C. J. C., Rees, J. R., Dennick, L. G., Maskin, C. S., Meyer, J. H., Schotz, W. E., Squibb, E. R., Brown, B. W., Zatuchni, J., Kjekshus, J., Swedberg Wilhelmsen, K. L., & Packer, M. (1987). Enalapril for Congestive Heart Failure. New England Journal of Medicine, 317(21), 1349-1351. https://doi.org/10.1056/NEJM198711193172112